GeneDx Holdings Corp.
WGS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $116,743 | $102,692 | $87,115 | $95,640 |
| % Growth | 13.7% | 17.9% | -8.9% | – |
| Cost of Goods Sold | $32,216 | $31,790 | $28,639 | $29,435 |
| Gross Profit | $84,527 | $70,902 | $58,476 | $66,205 |
| % Margin | 72.4% | 69% | 67.1% | 69.2% |
| R&D Expenses | $19,829 | $14,870 | $12,577 | $11,588 |
| G&A Expenses | $44,439 | $26,936 | $32,134 | $27,350 |
| SG&A Expenses | $67,949 | $46,384 | $50,450 | $45,026 |
| Sales & Mktg Exp. | $23,510 | $19,448 | $18,316 | $17,676 |
| Other Operating Expenses | $0 | $688 | $0 | $785 |
| Operating Expenses | $87,778 | $61,942 | $63,027 | $57,399 |
| Operating Income | -$3,251 | $8,960 | -$4,551 | $8,806 |
| % Margin | -2.8% | 8.7% | -5.2% | 9.2% |
| Other Income/Exp. Net | -$4,137 | $1,603 | -$1,531 | -$3,392 |
| Pre-Tax Income | -$7,388 | $10,563 | -$6,082 | $5,414 |
| Tax Expense | $247 | -$246 | $447 | -$24 |
| Net Income | -$7,635 | $10,809 | -$6,529 | $5,438 |
| % Margin | -6.5% | 10.5% | -7.5% | 5.7% |
| EPS | -0.27 | 0.38 | -0.23 | 0.2 |
| % Growth | -171.1% | 265.2% | -215% | – |
| EPS Diluted | -0.27 | 0.36 | -0.23 | 0.2 |
| Weighted Avg Shares Out | 28,798 | 28,580 | 28,148 | 26,994 |
| Weighted Avg Shares Out Dil | 28,798 | 29,754 | 28,148 | 26,994 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $562 | $817 | $640 | $698 |
| Depreciation & Amortization | $6,474 | $6,191 | $5,678 | $5,558 |
| EBITDA | -$352 | $17,571 | $236 | $14,364 |
| % Margin | -0.3% | 17.1% | 0.3% | 15% |